CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new synthetic methods to create β-lactam antibiotics using metal-catalyzed C–H activation. By screening various conditions to optimize this process, the goal is to produce compounds that can combat multidrug-resistant bacterial infections.
In Europe, infections caused by multidrug-resistant bacteria lead to more than 25,000 deaths and expenses of billions of euros per year.
These numbers dramatically increase when the rest of the world is taken into consideration.
Shockingly, the pace of production of new antibiotics to control such microorganisms is stagnating.
Therefore, developing new synthetic tools that enable the synthesis of scaffolds with potential antibiotic properties is crucial.
Metal catalysed C–H activation represents…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
